Curative Biosciences
CBDX · OTC
About CBDX
- Employees
- 0
- Headquarters
- Miami, Florida
- Listed
- Aug 26, 2004
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- curativebiosciences.com
CBDX key statistics
- Market cap
- 25.79K
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 12.79K
- Volume
- 200
- Open price
- $0.0001
- High today
- $0.0001
- Low today
- $0.0001
- 52 Week high
- $0.0002
- 52 Week low
- $0.0001
Curative Biosciences (CBDX) at a glance
Curative Biosciences (CBDX) last traded at $0.0001, with a market cap of 25.79K.
Volume so far is 200 shares, below the average of 12.79K shares a day.
Over the past year Curative Biosciences has ranged from $0.0001 to $0.0002, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as Curative Biosciences
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.